Loncastuximab Tesirine
ADCT-402-203
Phase 2 small_molecule active
Quick answer
Loncastuximab Tesirine for Diffuse Large B-cell Lymphoma is a Phase 2 program (small_molecule) at ADC Therapeutics SA with 4 ClinicalTrials.gov record(s).
Program details
- Company
- ADC Therapeutics SA
- Indication
- Diffuse Large B-cell Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active